FindMyKOL
Clinical trialNCT00024362UnknownPhase 2Interventional

BBR 3464 in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer That Cannot be Treated With Surgery

SponsorTheradexPancreatic Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of BBR 3464 in treating patients who have locally advanced or metastatic pancreatic cancer that cannot be treated with surgery.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

  • George L. Miller, MD

    Oklahoma Oncology, Incorporated at LaFortune Cancer Center

    Study Chair
    clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Arizona Oncology Associates

    Tucson, Arizona, United States

  • Alta Bates Comprehensive Cancer Center

    Berkeley, California, United States

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University

    Chicago, Illinois, United States

  • Albert B. Chandler Medical Center, University of Kentucky

    Lexington, Kentucky, United States

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts, United States

  • Oklahoma Oncology Inc.

    Tulsa, Oklahoma, United States

  • Boston Baskin Cancer Group, University Tennessee Oncology/hematology Group

    Memphis, Tennessee, United States

  • Cancer Center at the University of Virginia

    Charlottesville, Virginia, United States

  • Massey Cancer Center

    Richmond, Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BBR 3464
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2001
Primary completion
—
Completion
—
Last update posted
24 Jul 2008
Registered enrollment
—
Registry id
NCT00024362
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.